Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Thrombosis Research
|
April 15, 1994
2-[3-[2-(4,5-diphenyl-2-oxazolyl) ethyl] phenoxy] acetic acid (BMY 42393): 2). Oral activity and efficacy in animal models of arterial thrombosis
S M Seiler, J O Buchanan, W A Schumacher, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology
|
March 1, 1993
Prostacyclin agonists reduce early atherosclerosis in hyperlipidemic hamsters. Octimibate and BMY 42393 suppress monocyte chemotaxis, macrophage cholesteryl ester accumulation, scavenger receptor activity, and tumor necrosis factor production
M C Kowala, C E Mazzucco, K S Hartl, et al.
Regulatory Peptides
|
March 19, 1993
Binding and signal transduction of the cloned vascular angiotensin II (AT1a) receptor cDNA stably expressed in Chinese hamster ovary cells
M L Webb, H Monshizadegan, K E Dickinson, et al.
Thrombosis Research
|
April 15, 1994
2-[3-[2-(4,5-Diphenyl-2-oxazolyl) ethyl] phenoxy] acetic acid (BMY 42393): a new, structurally-novel prostacyclin partial agonist: 1). Inhibition of platelet aggregation and mechanism of action
S M Seiler, C L Brassard, M E Federici, et al.
Journal of Medicinal Chemistry
|
January 22, 1993
Active site-directed synthetic thrombin inhibitors: synthesis, in vitro and in vivo activity profile of BMY 44621 and analogs. An examination of the role of the amino group in the D-Phe-Pro-Arg-H series
N Balasubramanian, D R St Laurent, M E Federici, et al.
Thrombosis Research
|
November 1, 1989
Pharmacology of a potent, new antithrombotic agent, 1,3-dihydro-7,8-dimethyl-2H-imidazo[4,5-b]quinolin-2-one (BMY-20844)
J O Buchanan, J S Fleming, B T Cornish, et al.
Bioorganic & Medicinal Chemistry
|
August 1, 1995
Active site-directed thrombin inhibitors--II. Studies related to arginine/guanidine bioisosteres
D R St Laurent, N Balasubramanian, W T Han, et al.
Journal of Medicinal Chemistry
|
January 24, 1992
Structure-activity relationships associated with 3,4,5-triphenyl-1H-pyrazole-1-nonanoic acid, a nonprostanoid prostacyclin mimetic
N A Meanwell, M J Rosenfeld, J J Wright, et al.
The American Journal of Cardiology
|
December 1, 1989
Natural history of potentially lethal ventricular arrhythmias in patients treated with long-term antiarrhythmic drug therapy
H L Kennedy, M K Sprague, S M Homan, et al.
Journal of Medicinal Chemistry
|
November 21, 1998
1,2-Benzisothiazol-3-one 1,1-dioxide inhibitors of human mast cell tryptase
K D Combrink, H B Gülgeze, N A Meanwell, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Thrombosis Research
|
April 15, 1994
2-[3-[2-(4,5-diphenyl-2-oxazolyl) ethyl] phenoxy] acetic acid (BMY 42393): 2). Oral activity and efficacy in animal models of arterial thrombosis
S M Seiler, J O Buchanan, W A Schumacher, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology
|
March 1, 1993
Prostacyclin agonists reduce early atherosclerosis in hyperlipidemic hamsters. Octimibate and BMY 42393 suppress monocyte chemotaxis, macrophage cholesteryl ester accumulation, scavenger receptor activity, and tumor necrosis factor production
M C Kowala, C E Mazzucco, K S Hartl, et al.
Regulatory Peptides
|
March 19, 1993
Binding and signal transduction of the cloned vascular angiotensin II (AT1a) receptor cDNA stably expressed in Chinese hamster ovary cells
M L Webb, H Monshizadegan, K E Dickinson, et al.
Thrombosis Research
|
April 15, 1994
2-[3-[2-(4,5-Diphenyl-2-oxazolyl) ethyl] phenoxy] acetic acid (BMY 42393): a new, structurally-novel prostacyclin partial agonist: 1). Inhibition of platelet aggregation and mechanism of action
S M Seiler, C L Brassard, M E Federici, et al.
Journal of Medicinal Chemistry
|
January 22, 1993
Active site-directed synthetic thrombin inhibitors: synthesis, in vitro and in vivo activity profile of BMY 44621 and analogs. An examination of the role of the amino group in the D-Phe-Pro-Arg-H series
N Balasubramanian, D R St Laurent, M E Federici, et al.
Thrombosis Research
|
November 1, 1989
Pharmacology of a potent, new antithrombotic agent, 1,3-dihydro-7,8-dimethyl-2H-imidazo[4,5-b]quinolin-2-one (BMY-20844)
J O Buchanan, J S Fleming, B T Cornish, et al.
Bioorganic & Medicinal Chemistry
|
August 1, 1995
Active site-directed thrombin inhibitors--II. Studies related to arginine/guanidine bioisosteres
D R St Laurent, N Balasubramanian, W T Han, et al.
Journal of Medicinal Chemistry
|
January 24, 1992
Structure-activity relationships associated with 3,4,5-triphenyl-1H-pyrazole-1-nonanoic acid, a nonprostanoid prostacyclin mimetic
N A Meanwell, M J Rosenfeld, J J Wright, et al.
The American Journal of Cardiology
|
December 1, 1989
Natural history of potentially lethal ventricular arrhythmias in patients treated with long-term antiarrhythmic drug therapy
H L Kennedy, M K Sprague, S M Homan, et al.
Journal of Medicinal Chemistry
|
November 21, 1998
1,2-Benzisothiazol-3-one 1,1-dioxide inhibitors of human mast cell tryptase
K D Combrink, H B Gülgeze, N A Meanwell, et al.
Page
of 4